Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Economy
M&A·IB

[Oil Drive] Although the President’s Visit to South Korea Was Canceled… the UAE’s Foreign Investment Strategy Is “Still Underway”

The global investment banking (IB) industry is turning its attention to the Middle East, home to a host of the world’s largest sovereign wealth funds. “Oil Drive” is a series covering news from the Mi…
  • 2026-11-17 09:21:04
  • Soyoung Park
M&A·IB

[37th SRE][Survey] Han Shin Rating Ranks Last Across All Categories, from Credibility to Reports

Korea Ratings plummeted to third place—the lowest ranking—in the “Credit Rating Reliability” category of the 37th SRE. In addition to rating reliability, Korea Ratings ranked third in all four categor…
  • 2026-11-17 09:00:07
  • Hur Jieun
Business·Industry

[Exclusive] "Will My Stock Be Delisted, Too?"… 150 Companies Facing Delisting, but the Ripple Effects Remain Unclear

As delisting requirements for underperforming listed companies are being significantly tightened—leading to growing confusion among companies and investors—the venture capital industry is raising ques…
  • 2026-11-17 08:39:53
  • Kweon A-in
Financing

[37th SRE][Survey] NICE Credit Rating, “One Step Ahead,” Ranks Second in Trustworthiness for the First Time in Three Years

NICE Credit Rating (NICE) ranked second in the credit rating reliability category of the 37th Edaily Survey of Credit Rating Experts (SRE). It was the only one of the three major credit rating agencie…
  • 2026-11-17 08:35:04
  • LEE GEON-EOM
Bonds·FX Policy

[37th SRE][Survey] Korea Ratings, Ranked No. 1 in Trustworthiness for the Fifth Consecutive Year

Korea Ratings & Investment Services (KRIS) ranked first (3.78 points) in the “Credit Rating Reliability” category at the 37th SRE. This marks the fifth consecutive time—since the 33rd SRE—that KRIS ha…
  • 2026-11-17 08:15:04
  • KIM YEON-SEO
Bonds·FX Policy

[37th SRE][Survey] How Did the 37th SRE Go?

Edaily’s annual “Survey of Credit Ratings by Edaily” (SRE), which has been conducted among corporate bond market experts since 2005, has reached its 37th edition. The SRE is a regular survey in which …
  • 2026-11-17 08:02:03
  • KIM YEON-SEO
Business·Industry

[Exclusive] Company Hints at Legal Battle with Largest Shareholder… Key Issue: Abolition of Supermajority Voting [OSCOTEC Inc. Dispute, Part 2]

September 22. With the Chuseok holiday just two days away, many people were buzzing with anticipation for the long weekend. However, the largest shareholder, standing in the public service office of t…
  • 2026-11-17 08:01:02
  • Kim Jinsoo
Financing

[37th SRE][Survey] Credit Rating Agencies’ Trust Rating Remains in the “4s” for Fourth Consecutive Year… Individual Agencies Show “Stagnation”

The credibility of domestic credit rating agencies has remained in the 4-point range for four consecutive years. Since first exceeding 4 points in the 34th Edaily Credit Rating Expert Survey (SRE: Sur…
  • 2026-11-17 08:00:06
  • LEE GEON-EOM
M&A·IB

[37th SRE][Cover] “Like selling rotten apples with an ‘eco-friendly certification’ label”… Responsibility placed solely on individuals

“It’s like selling apples with worms in them—Homeplus simply displayed them on the shelves and sold them, while JTBC sold them with an eco-friendly certification called ‘public offering’ attached.” Le…
  • 2026-11-17 07:30:05
  • Song Seung-Hyeon
Business·Industry

Voronoi, Inc.: Effect of VRN10 by Dosage Remains Unclear… Possibility of Further Analysis

Voronoi, Inc.(310210)’s new anticancer drug candidate “VRN10” (VRN101099) demonstrated early antitumor activity by achieving a partial response (PR) in patients with HER2-mutated solid tumors. However…
  • 2026-11-17 07:06:03
  • Kim Jinsoo
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English